Debashis Ghosh
Concepts (750)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Data Interpretation, Statistical | 28 | 2020 | 338 | 4.720 |
Why?
| Models, Statistical | 44 | 2024 | 624 | 4.720 |
Why?
| Gene Expression Profiling | 55 | 2023 | 1686 | 4.650 |
Why?
| Algorithms | 40 | 2024 | 1617 | 4.200 |
Why?
| Oligonucleotide Array Sequence Analysis | 38 | 2016 | 756 | 3.440 |
Why?
| Machine Learning | 10 | 2024 | 441 | 2.790 |
Why?
| Computer Simulation | 36 | 2024 | 941 | 2.730 |
Why?
| Biomarkers, Tumor | 25 | 2022 | 1161 | 2.320 |
Why?
| Metabolomics | 9 | 2022 | 652 | 2.250 |
Why?
| Biometry | 13 | 2011 | 69 | 2.160 |
Why?
| Computational Biology | 19 | 2024 | 593 | 2.030 |
Why?
| Prostatic Neoplasms | 28 | 2024 | 999 | 1.900 |
Why?
| Neoplasms | 25 | 2024 | 2454 | 1.810 |
Why?
| Regression Analysis | 13 | 2021 | 998 | 1.490 |
Why?
| Genomics | 12 | 2024 | 716 | 1.400 |
Why?
| Neoplasm Proteins | 12 | 2018 | 417 | 1.350 |
Why?
| Pulmonary Disease, Chronic Obstructive | 4 | 2023 | 1000 | 1.340 |
Why?
| Models, Biological | 14 | 2021 | 1724 | 1.330 |
Why?
| Gene Expression Regulation, Neoplastic | 24 | 2021 | 1327 | 1.310 |
Why?
| Databases, Factual | 12 | 2024 | 1269 | 1.180 |
Why?
| Biomarkers | 14 | 2021 | 3971 | 1.170 |
Why?
| Causality | 4 | 2022 | 117 | 1.160 |
Why?
| Statistics, Nonparametric | 8 | 2019 | 422 | 1.160 |
Why?
| Proportional Hazards Models | 10 | 2022 | 1199 | 1.140 |
Why?
| Humans | 177 | 2025 | 129847 | 1.140 |
Why?
| Software | 14 | 2022 | 608 | 1.100 |
Why?
| Biostatistics | 3 | 2014 | 16 | 1.080 |
Why?
| Leishmaniasis, Visceral | 2 | 2024 | 7 | 1.030 |
Why?
| Survival Analysis | 12 | 2024 | 1271 | 1.020 |
Why?
| Meta-Analysis as Topic | 4 | 2014 | 170 | 0.940 |
Why?
| Natural Gas | 1 | 2025 | 24 | 0.940 |
Why?
| Oil and Gas Fields | 1 | 2025 | 31 | 0.930 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2025 | 279 | 0.920 |
Why?
| Leishmaniasis, Cutaneous | 1 | 2024 | 10 | 0.910 |
Why?
| Endemic Diseases | 1 | 2024 | 31 | 0.900 |
Why?
| Microscopy | 3 | 2023 | 140 | 0.890 |
Why?
| Magnetoencephalography | 2 | 2021 | 128 | 0.890 |
Why?
| Colonic Neoplasms | 2 | 2022 | 241 | 0.860 |
Why?
| Environmental Exposure | 3 | 2025 | 463 | 0.850 |
Why?
| Histological Techniques | 1 | 2023 | 40 | 0.840 |
Why?
| Lung Neoplasms | 6 | 2022 | 2344 | 0.820 |
Why?
| Genetic Association Studies | 5 | 2019 | 357 | 0.810 |
Why?
| Models, Genetic | 11 | 2019 | 592 | 0.800 |
Why?
| Multivariate Analysis | 16 | 2022 | 1501 | 0.800 |
Why?
| Cognitive Dysfunction | 4 | 2021 | 347 | 0.790 |
Why?
| Connectome | 2 | 2021 | 84 | 0.750 |
Why?
| Parkinsonian Disorders | 1 | 2021 | 34 | 0.730 |
Why?
| Mass Spectrometry | 6 | 2022 | 717 | 0.730 |
Why?
| Brain | 4 | 2024 | 2677 | 0.710 |
Why?
| Propensity Score | 4 | 2018 | 266 | 0.700 |
Why?
| Endpoint Determination | 2 | 2011 | 76 | 0.690 |
Why?
| Brain Mapping | 2 | 2021 | 575 | 0.690 |
Why?
| Feasibility Studies | 1 | 2024 | 870 | 0.670 |
Why?
| Phenotype | 12 | 2023 | 3062 | 0.670 |
Why?
| Clinical Trials as Topic | 4 | 2022 | 1005 | 0.660 |
Why?
| Cluster Analysis | 11 | 2024 | 483 | 0.650 |
Why?
| High-Throughput Screening Assays | 2 | 2012 | 139 | 0.650 |
Why?
| Risk Assessment | 8 | 2020 | 3269 | 0.650 |
Why?
| Image Processing, Computer-Assisted | 7 | 2024 | 739 | 0.640 |
Why?
| Diagnostic Imaging | 1 | 2022 | 326 | 0.640 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 99 | 0.630 |
Why?
| Databases, Genetic | 11 | 2021 | 228 | 0.630 |
Why?
| Learning | 1 | 2023 | 403 | 0.630 |
Why?
| Genetic Variation | 4 | 2019 | 937 | 0.630 |
Why?
| Quantitative Trait, Heritable | 2 | 2018 | 121 | 0.610 |
Why?
| DNA Copy Number Variations | 2 | 2017 | 167 | 0.610 |
Why?
| Metabolome | 1 | 2021 | 339 | 0.590 |
Why?
| Glioma | 1 | 2022 | 351 | 0.590 |
Why?
| Transcriptome | 2 | 2023 | 875 | 0.580 |
Why?
| Randomized Controlled Trials as Topic | 5 | 2021 | 1368 | 0.570 |
Why?
| Logistic Models | 12 | 2020 | 1989 | 0.570 |
Why?
| Cardiovascular Diseases | 5 | 2022 | 2008 | 0.570 |
Why?
| Reproducibility of Results | 17 | 2021 | 3089 | 0.570 |
Why?
| Epidemiologic Methods | 2 | 2007 | 74 | 0.540 |
Why?
| Immunohistochemistry | 11 | 2022 | 1690 | 0.530 |
Why?
| Registries | 2 | 2024 | 1903 | 0.520 |
Why?
| Retinol-Binding Proteins | 2 | 2014 | 14 | 0.520 |
Why?
| Male | 67 | 2025 | 63759 | 0.520 |
Why?
| Eye Proteins | 3 | 2014 | 88 | 0.510 |
Why?
| Markov Chains | 7 | 2017 | 117 | 0.490 |
Why?
| Linear Models | 7 | 2018 | 822 | 0.480 |
Why?
| Case-Control Studies | 10 | 2025 | 3384 | 0.460 |
Why?
| Empirical Research | 2 | 2012 | 21 | 0.460 |
Why?
| Autism Spectrum Disorder | 2 | 2017 | 386 | 0.450 |
Why?
| Diagnosis, Computer-Assisted | 4 | 2008 | 86 | 0.450 |
Why?
| Carcinoma, Squamous Cell | 4 | 2017 | 628 | 0.450 |
Why?
| Nerve Net | 3 | 2024 | 260 | 0.440 |
Why?
| Neuroendocrine Tumors | 3 | 2024 | 99 | 0.430 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1050 | 0.430 |
Why?
| Genome-Wide Association Study | 7 | 2018 | 1326 | 0.420 |
Why?
| Bayes Theorem | 6 | 2012 | 374 | 0.420 |
Why?
| Protein Tyrosine Phosphatases | 3 | 2019 | 165 | 0.410 |
Why?
| Bias | 5 | 2022 | 197 | 0.410 |
Why?
| Disease Progression | 15 | 2021 | 2628 | 0.400 |
Why?
| Tissue Array Analysis | 3 | 2008 | 55 | 0.390 |
Why?
| Treatment Outcome | 8 | 2021 | 10241 | 0.390 |
Why?
| Oncogenes | 1 | 2013 | 110 | 0.390 |
Why?
| Aromatase | 1 | 2012 | 31 | 0.380 |
Why?
| Sulfhydryl Compounds | 1 | 2014 | 187 | 0.370 |
Why?
| Genome | 5 | 2017 | 278 | 0.370 |
Why?
| Cardiac Catheterization | 1 | 2015 | 520 | 0.360 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2012 | 151 | 0.360 |
Why?
| Diabetes Mellitus, Type 2 | 3 | 2022 | 2444 | 0.360 |
Why?
| Female | 47 | 2025 | 68829 | 0.360 |
Why?
| Nerve Tissue Proteins | 4 | 2023 | 569 | 0.360 |
Why?
| Alzheimer Disease | 3 | 2015 | 516 | 0.350 |
Why?
| Adenocarcinoma | 4 | 2017 | 893 | 0.340 |
Why?
| Supervised Machine Learning | 2 | 2021 | 17 | 0.340 |
Why?
| Polymorphism, Single Nucleotide | 5 | 2019 | 2062 | 0.340 |
Why?
| Antioxidants | 1 | 2014 | 558 | 0.330 |
Why?
| Models, Neurological | 2 | 2024 | 240 | 0.330 |
Why?
| Colorado | 6 | 2025 | 4410 | 0.330 |
Why?
| Liver Neoplasms | 1 | 2015 | 636 | 0.330 |
Why?
| Gene Expression | 3 | 2014 | 1465 | 0.330 |
Why?
| Aged | 29 | 2024 | 22107 | 0.320 |
Why?
| Stem Cells | 3 | 2020 | 578 | 0.320 |
Why?
| Endoplasmic Reticulum | 1 | 2012 | 261 | 0.320 |
Why?
| Ki-67 Antigen | 2 | 2020 | 108 | 0.320 |
Why?
| Epidemiologic Research Design | 1 | 2009 | 27 | 0.320 |
Why?
| Risk Factors | 14 | 2025 | 9801 | 0.320 |
Why?
| Gene Dosage | 1 | 2010 | 143 | 0.310 |
Why?
| Child, Preschool | 7 | 2025 | 10522 | 0.310 |
Why?
| Chromatin Immunoprecipitation | 3 | 2017 | 132 | 0.310 |
Why?
| Proteomics | 5 | 2009 | 1058 | 0.300 |
Why?
| Bone Marrow Transplantation | 2 | 2008 | 277 | 0.300 |
Why?
| Protein Array Analysis | 8 | 2009 | 56 | 0.300 |
Why?
| Signal Transduction | 9 | 2023 | 4935 | 0.300 |
Why?
| Carcinoma | 2 | 2007 | 213 | 0.300 |
Why?
| Sensitivity and Specificity | 10 | 2015 | 1847 | 0.300 |
Why?
| Tumor Microenvironment | 2 | 2022 | 627 | 0.290 |
Why?
| Emigration and Immigration | 1 | 2008 | 49 | 0.290 |
Why?
| Racemases and Epimerases | 5 | 2006 | 11 | 0.290 |
Why?
| Statistical Distributions | 1 | 2008 | 8 | 0.290 |
Why?
| Middle Aged | 31 | 2024 | 31177 | 0.290 |
Why?
| Probability | 3 | 2021 | 304 | 0.290 |
Why?
| Chromosome Mapping | 6 | 2017 | 499 | 0.280 |
Why?
| DNA-Binding Proteins | 7 | 2018 | 1441 | 0.280 |
Why?
| DNA Methylation | 4 | 2023 | 606 | 0.280 |
Why?
| Arrhythmias, Cardiac | 2 | 2020 | 322 | 0.280 |
Why?
| Child | 13 | 2025 | 20962 | 0.280 |
Why?
| Research Design | 5 | 2021 | 1045 | 0.280 |
Why?
| Crystallography, X-Ray | 4 | 2019 | 438 | 0.270 |
Why?
| Flow Cytometry | 2 | 2022 | 1160 | 0.270 |
Why?
| Tumor Burden | 1 | 2008 | 287 | 0.270 |
Why?
| Proteome | 3 | 2007 | 440 | 0.260 |
Why?
| Pancreas | 2 | 2020 | 305 | 0.260 |
Why?
| Urinary Bladder Neoplasms | 2 | 2021 | 226 | 0.260 |
Why?
| Bangladesh | 2 | 2024 | 42 | 0.260 |
Why?
| Diabetes Mellitus | 5 | 2022 | 1003 | 0.250 |
Why?
| Monte Carlo Method | 4 | 2017 | 143 | 0.250 |
Why?
| Triple Negative Breast Neoplasms | 2 | 2019 | 193 | 0.240 |
Why?
| Placenta | 1 | 2012 | 716 | 0.240 |
Why?
| Neoplasm Staging | 6 | 2019 | 1282 | 0.240 |
Why?
| Cell Proliferation | 5 | 2021 | 2378 | 0.240 |
Why?
| False Positive Reactions | 4 | 2012 | 114 | 0.230 |
Why?
| Cell Nucleus | 2 | 2019 | 590 | 0.230 |
Why?
| Homeodomain Proteins | 4 | 2020 | 493 | 0.230 |
Why?
| Magnetic Resonance Imaging | 5 | 2022 | 3397 | 0.230 |
Why?
| Replication Origin | 1 | 2004 | 17 | 0.230 |
Why?
| Genetic Predisposition to Disease | 5 | 2023 | 2271 | 0.230 |
Why?
| Adult | 21 | 2024 | 35634 | 0.220 |
Why?
| Data Curation | 1 | 2024 | 11 | 0.220 |
Why?
| Weather | 1 | 2024 | 35 | 0.220 |
Why?
| Neoplasm Recurrence, Local | 3 | 2019 | 957 | 0.220 |
Why?
| Leukemia | 1 | 2006 | 230 | 0.220 |
Why?
| ROC Curve | 5 | 2020 | 504 | 0.220 |
Why?
| Carrier Proteins | 2 | 2007 | 741 | 0.220 |
Why?
| Antigens | 1 | 2005 | 356 | 0.210 |
Why?
| Histones | 4 | 2020 | 588 | 0.210 |
Why?
| Melanoma | 3 | 2005 | 730 | 0.210 |
Why?
| Lupus Nephritis | 1 | 2023 | 49 | 0.210 |
Why?
| Cell Phone | 1 | 2024 | 70 | 0.210 |
Why?
| Statistics as Topic | 2 | 2005 | 306 | 0.210 |
Why?
| Sample Size | 3 | 2008 | 116 | 0.210 |
Why?
| Coculture Techniques | 1 | 2004 | 224 | 0.210 |
Why?
| Staining and Labeling | 1 | 2023 | 143 | 0.210 |
Why?
| Common Variable Immunodeficiency | 1 | 2023 | 26 | 0.200 |
Why?
| Membrane Transport Proteins | 1 | 2004 | 149 | 0.200 |
Why?
| Carcinogens | 1 | 2003 | 109 | 0.200 |
Why?
| Social Stigma | 1 | 2024 | 117 | 0.200 |
Why?
| Organometallic Compounds | 1 | 2023 | 106 | 0.200 |
Why?
| Personality | 1 | 2004 | 124 | 0.200 |
Why?
| Neoplasms, Experimental | 1 | 2003 | 171 | 0.200 |
Why?
| Breast Neoplasms | 7 | 2014 | 2104 | 0.200 |
Why?
| Emphysema | 1 | 2023 | 109 | 0.200 |
Why?
| Neuroimaging | 2 | 2015 | 279 | 0.190 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 2 | 2019 | 115 | 0.190 |
Why?
| Tomography, X-Ray Computed | 2 | 2023 | 2511 | 0.190 |
Why?
| Infant | 3 | 2024 | 9018 | 0.190 |
Why?
| Promoter Regions, Genetic | 3 | 2009 | 1213 | 0.190 |
Why?
| Membrane Glycoproteins | 1 | 2004 | 477 | 0.180 |
Why?
| Brain Waves | 1 | 2021 | 31 | 0.180 |
Why?
| Head and Neck Neoplasms | 2 | 2017 | 544 | 0.180 |
Why?
| Epilepsies, Partial | 1 | 2021 | 43 | 0.180 |
Why?
| Analysis of Variance | 4 | 2024 | 1291 | 0.180 |
Why?
| Epilepsy | 2 | 2021 | 322 | 0.180 |
Why?
| Receptors, Androgen | 2 | 2021 | 143 | 0.180 |
Why?
| Polymorphism, Genetic | 1 | 2004 | 636 | 0.180 |
Why?
| Autoantibodies | 5 | 2020 | 1468 | 0.180 |
Why?
| Genotype | 8 | 2019 | 1829 | 0.180 |
Why?
| Anxiety Disorders | 1 | 2004 | 357 | 0.180 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2023 | 247 | 0.180 |
Why?
| Peptides | 4 | 2007 | 926 | 0.180 |
Why?
| Adolescent | 8 | 2024 | 20451 | 0.170 |
Why?
| Hyaluronan Receptors | 1 | 2021 | 97 | 0.170 |
Why?
| RNA, Messenger | 8 | 2024 | 2703 | 0.170 |
Why?
| Pulmonary Emphysema | 1 | 2023 | 275 | 0.170 |
Why?
| Drug Resistant Epilepsy | 1 | 2021 | 81 | 0.170 |
Why?
| Lymphocytes | 2 | 2023 | 377 | 0.170 |
Why?
| Pattern Recognition, Automated | 4 | 2009 | 75 | 0.170 |
Why?
| Precision Medicine | 1 | 2024 | 385 | 0.170 |
Why?
| Recurrence | 4 | 2010 | 1013 | 0.160 |
Why?
| Artificial Intelligence | 3 | 2008 | 245 | 0.160 |
Why?
| Radiography | 1 | 2022 | 800 | 0.160 |
Why?
| Toll-Like Receptors | 1 | 2020 | 179 | 0.160 |
Why?
| Mexican Americans | 3 | 2008 | 113 | 0.160 |
Why?
| Exome | 2 | 2018 | 216 | 0.160 |
Why?
| Herpes Zoster Vaccine | 1 | 2022 | 162 | 0.160 |
Why?
| Hospital Mortality | 1 | 2024 | 852 | 0.160 |
Why?
| Protein Binding | 5 | 2019 | 2123 | 0.160 |
Why?
| Tretinoin | 1 | 2020 | 121 | 0.160 |
Why?
| Tandem Mass Spectrometry | 3 | 2014 | 528 | 0.160 |
Why?
| Prognosis | 11 | 2021 | 3773 | 0.160 |
Why?
| Intensive Care Units | 1 | 2024 | 738 | 0.150 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2019 | 40 | 0.150 |
Why?
| Bone Regeneration | 1 | 2019 | 24 | 0.150 |
Why?
| Disease | 1 | 2019 | 94 | 0.150 |
Why?
| Gene Expression Regulation | 4 | 2014 | 2545 | 0.150 |
Why?
| Functional Neuroimaging | 1 | 2019 | 73 | 0.150 |
Why?
| Small Molecule Libraries | 1 | 2019 | 86 | 0.150 |
Why?
| Precancerous Conditions | 1 | 2020 | 160 | 0.150 |
Why?
| Pancreatic Neoplasms | 3 | 2019 | 879 | 0.150 |
Why?
| Nuclear Proteins | 2 | 2019 | 660 | 0.150 |
Why?
| Multiple Sclerosis | 1 | 2024 | 438 | 0.150 |
Why?
| Pituitary Gland | 2 | 2009 | 148 | 0.150 |
Why?
| SOXB1 Transcription Factors | 1 | 2019 | 57 | 0.150 |
Why?
| Neoplasms, Second Primary | 1 | 2019 | 106 | 0.150 |
Why?
| Protein Structure, Tertiary | 3 | 2012 | 844 | 0.150 |
Why?
| Genetic Markers | 3 | 2015 | 334 | 0.150 |
Why?
| Herpes Zoster | 1 | 2022 | 317 | 0.150 |
Why?
| Patient Acceptance of Health Care | 1 | 2024 | 763 | 0.150 |
Why?
| Wilms Tumor | 1 | 2019 | 78 | 0.150 |
Why?
| Animals | 19 | 2021 | 35409 | 0.140 |
Why?
| Protein Phosphatase 2 | 1 | 2018 | 38 | 0.140 |
Why?
| Observational Studies as Topic | 1 | 2018 | 110 | 0.140 |
Why?
| Monocytes | 1 | 2020 | 554 | 0.140 |
Why?
| RNA, Small Interfering | 2 | 2019 | 590 | 0.140 |
Why?
| Mice | 15 | 2021 | 16983 | 0.140 |
Why?
| RNA, Neoplasm | 1 | 2017 | 82 | 0.140 |
Why?
| CD24 Antigen | 1 | 2017 | 20 | 0.140 |
Why?
| Genes, Neoplasm | 3 | 2007 | 20 | 0.140 |
Why?
| Cross-Sectional Studies | 3 | 2024 | 5085 | 0.140 |
Why?
| DNA, Neoplasm | 1 | 2017 | 154 | 0.140 |
Why?
| Clinical Laboratory Techniques | 1 | 2018 | 94 | 0.140 |
Why?
| Osteogenesis | 1 | 2019 | 175 | 0.140 |
Why?
| Young Adult | 7 | 2024 | 12467 | 0.140 |
Why?
| Epigenomics | 1 | 2017 | 110 | 0.140 |
Why?
| Neoplasm Metastasis | 6 | 2019 | 610 | 0.130 |
Why?
| Clinical Trials, Phase III as Topic | 3 | 2012 | 94 | 0.130 |
Why?
| Child Health | 1 | 2019 | 147 | 0.130 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2019 | 252 | 0.130 |
Why?
| Transcription, Genetic | 7 | 2013 | 1416 | 0.130 |
Why?
| RNA, Viral | 2 | 2024 | 620 | 0.130 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 129 | 0.130 |
Why?
| Beryllium | 1 | 2018 | 152 | 0.130 |
Why?
| Up-Regulation | 2 | 2018 | 836 | 0.130 |
Why?
| Induction Chemotherapy | 1 | 2017 | 70 | 0.130 |
Why?
| Principal Component Analysis | 1 | 2017 | 190 | 0.130 |
Why?
| Tachycardia, Ventricular | 1 | 2018 | 168 | 0.130 |
Why?
| Chemoradiotherapy, Adjuvant | 1 | 2016 | 41 | 0.130 |
Why?
| Lung Diseases, Interstitial | 1 | 2023 | 611 | 0.130 |
Why?
| Chromosome Aberrations | 2 | 2007 | 140 | 0.130 |
Why?
| Lymph Nodes | 1 | 2019 | 471 | 0.130 |
Why?
| Nurse Anesthetists | 1 | 2016 | 3 | 0.130 |
Why?
| Anesthesia Department, Hospital | 1 | 2016 | 2 | 0.130 |
Why?
| Transcription Factors | 6 | 2017 | 1645 | 0.130 |
Why?
| Normal Distribution | 2 | 2014 | 21 | 0.130 |
Why?
| Anesthesia, Obstetrical | 1 | 2016 | 7 | 0.130 |
Why?
| Memory, Short-Term | 1 | 2019 | 258 | 0.130 |
Why?
| Salivary Gland Neoplasms | 1 | 2016 | 34 | 0.130 |
Why?
| DNA, Complementary | 3 | 2005 | 266 | 0.130 |
Why?
| Tumor Cells, Cultured | 5 | 2021 | 931 | 0.130 |
Why?
| Aged, 80 and over | 13 | 2022 | 7066 | 0.130 |
Why?
| Anus Neoplasms | 1 | 2016 | 30 | 0.130 |
Why?
| Heart Arrest | 1 | 2020 | 323 | 0.130 |
Why?
| Anesthesiologists | 1 | 2016 | 20 | 0.130 |
Why?
| ErbB Receptors | 2 | 2012 | 605 | 0.130 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 443 | 0.130 |
Why?
| Kaplan-Meier Estimate | 3 | 2017 | 851 | 0.130 |
Why?
| Analgesia, Obstetrical | 1 | 2016 | 20 | 0.130 |
Why?
| Protein Conformation | 2 | 2012 | 861 | 0.130 |
Why?
| Transcriptional Activation | 1 | 2018 | 366 | 0.130 |
Why?
| Hypoglycemic Agents | 2 | 2021 | 1221 | 0.130 |
Why?
| Models, Theoretical | 1 | 2020 | 549 | 0.130 |
Why?
| B7-H1 Antigen | 1 | 2018 | 198 | 0.130 |
Why?
| Berylliosis | 1 | 2018 | 185 | 0.130 |
Why?
| Parkinson Disease | 1 | 2021 | 462 | 0.130 |
Why?
| Health Services Research | 1 | 2019 | 392 | 0.130 |
Why?
| Anal Canal | 1 | 2016 | 88 | 0.120 |
Why?
| Host-Pathogen Interactions | 1 | 2019 | 355 | 0.120 |
Why?
| Respiratory Sounds | 2 | 2007 | 118 | 0.120 |
Why?
| Air Pollution | 2 | 2017 | 218 | 0.120 |
Why?
| Cough | 2 | 2007 | 117 | 0.120 |
Why?
| Insulin-Secreting Cells | 1 | 2020 | 367 | 0.120 |
Why?
| Cell Transformation, Neoplastic | 4 | 2007 | 319 | 0.120 |
Why?
| Defibrillators, Implantable | 1 | 2018 | 300 | 0.120 |
Why?
| HIV Infections | 3 | 2022 | 2730 | 0.120 |
Why?
| Atrial Fibrillation | 1 | 2020 | 376 | 0.120 |
Why?
| Kidney Neoplasms | 1 | 2019 | 347 | 0.120 |
Why?
| Colorectal Neoplasms | 3 | 2012 | 748 | 0.120 |
Why?
| Cancer Survivors | 1 | 2019 | 257 | 0.120 |
Why?
| Risk | 1 | 2017 | 860 | 0.120 |
Why?
| Schizophrenia | 1 | 2019 | 432 | 0.120 |
Why?
| Gastrointestinal Microbiome | 1 | 2022 | 641 | 0.120 |
Why?
| Blood Glucose | 2 | 2022 | 2103 | 0.120 |
Why?
| Hypocreales | 1 | 2014 | 8 | 0.110 |
Why?
| Cell Differentiation | 2 | 2020 | 1900 | 0.110 |
Why?
| Neoplastic Stem Cells | 1 | 2019 | 378 | 0.110 |
Why?
| Time Factors | 5 | 2016 | 6550 | 0.110 |
Why?
| Executive Function | 1 | 2019 | 433 | 0.110 |
Why?
| Discriminant Analysis | 3 | 2020 | 39 | 0.110 |
Why?
| Ants | 1 | 2014 | 25 | 0.110 |
Why?
| Cell Line, Tumor | 7 | 2019 | 3185 | 0.110 |
Why?
| Metmyoglobin | 1 | 2014 | 2 | 0.110 |
Why?
| Survival Rate | 4 | 2019 | 1872 | 0.110 |
Why?
| Sulfonic Acids | 1 | 2014 | 13 | 0.110 |
Why?
| Influenza Vaccines | 1 | 2019 | 533 | 0.110 |
Why?
| Longitudinal Studies | 4 | 2018 | 2724 | 0.110 |
Why?
| Treatment Failure | 1 | 2015 | 339 | 0.110 |
Why?
| Chromatography, Ion Exchange | 1 | 2014 | 52 | 0.110 |
Why?
| Benzothiazoles | 1 | 2014 | 32 | 0.110 |
Why?
| Chromatography, Affinity | 1 | 2014 | 83 | 0.110 |
Why?
| Chromatography, Gel | 1 | 2014 | 126 | 0.110 |
Why?
| Free Radical Scavengers | 1 | 2014 | 83 | 0.110 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 2015 | 228 | 0.110 |
Why?
| Brain Diseases | 1 | 2015 | 134 | 0.110 |
Why?
| Odds Ratio | 3 | 2020 | 1022 | 0.110 |
Why?
| Crystallization | 1 | 2014 | 137 | 0.110 |
Why?
| Cohort Studies | 8 | 2017 | 5444 | 0.100 |
Why?
| Embryonic Stem Cells | 1 | 2014 | 118 | 0.100 |
Why?
| Spectrometry, Fluorescence | 1 | 2014 | 164 | 0.100 |
Why?
| Trans-Activators | 3 | 2020 | 392 | 0.100 |
Why?
| Influenza, Human | 1 | 2019 | 602 | 0.100 |
Why?
| Estradiol | 2 | 2014 | 494 | 0.100 |
Why?
| Electronic Health Records | 1 | 2020 | 979 | 0.100 |
Why?
| Positron-Emission Tomography | 2 | 2024 | 282 | 0.100 |
Why?
| Xenograft Model Antitumor Assays | 3 | 2021 | 808 | 0.100 |
Why?
| Influenza A Virus, H5N1 Subtype | 1 | 2011 | 7 | 0.100 |
Why?
| Repressor Proteins | 2 | 2007 | 404 | 0.100 |
Why?
| Mice, Inbred BALB C | 3 | 2019 | 1248 | 0.090 |
Why?
| Least-Squares Analysis | 2 | 2020 | 79 | 0.090 |
Why?
| Arthritis, Rheumatoid | 1 | 2020 | 1098 | 0.090 |
Why?
| Gene Silencing | 3 | 2007 | 190 | 0.090 |
Why?
| Transcription Factor Pit-1 | 1 | 2011 | 24 | 0.090 |
Why?
| Otx Transcription Factors | 1 | 2011 | 13 | 0.090 |
Why?
| Hypopituitarism | 1 | 2011 | 16 | 0.090 |
Why?
| Motion | 1 | 2012 | 98 | 0.090 |
Why?
| Retina | 1 | 2014 | 283 | 0.090 |
Why?
| Heme | 1 | 2012 | 77 | 0.090 |
Why?
| Brucella suis | 1 | 2011 | 1 | 0.090 |
Why?
| Brucellosis | 1 | 2011 | 2 | 0.090 |
Why?
| Regulatory Sequences, Nucleic Acid | 2 | 2017 | 88 | 0.090 |
Why?
| Caspase 2 | 1 | 2011 | 13 | 0.090 |
Why?
| Gene Expression Regulation, Viral | 1 | 2011 | 90 | 0.090 |
Why?
| Prostatic Intraepithelial Neoplasia | 2 | 2008 | 11 | 0.090 |
Why?
| Chemoradiotherapy | 3 | 2017 | 208 | 0.090 |
Why?
| Lipid Bilayers | 1 | 2012 | 97 | 0.090 |
Why?
| Cattle | 1 | 2014 | 978 | 0.090 |
Why?
| Lung | 2 | 2023 | 3940 | 0.090 |
Why?
| MicroRNAs | 1 | 2017 | 680 | 0.090 |
Why?
| Catalytic Domain | 1 | 2012 | 218 | 0.090 |
Why?
| Age Factors | 3 | 2020 | 3161 | 0.090 |
Why?
| Catalysis | 1 | 2012 | 312 | 0.090 |
Why?
| Stress Disorders, Post-Traumatic | 2 | 2019 | 813 | 0.090 |
Why?
| Pharmacogenetics | 1 | 2012 | 172 | 0.090 |
Why?
| Neoplasm Invasiveness | 4 | 2017 | 484 | 0.090 |
Why?
| Pediatrics | 1 | 2019 | 1074 | 0.090 |
Why?
| Chemokines | 1 | 2011 | 227 | 0.090 |
Why?
| Vaccination | 1 | 2019 | 1348 | 0.090 |
Why?
| Mental Disorders | 1 | 2019 | 1035 | 0.090 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 146 | 0.080 |
Why?
| Zalcitabine | 1 | 2010 | 2 | 0.080 |
Why?
| Didanosine | 1 | 2010 | 13 | 0.080 |
Why?
| Nonlinear Dynamics | 1 | 2010 | 88 | 0.080 |
Why?
| Oxidation-Reduction | 1 | 2014 | 1031 | 0.080 |
Why?
| Prevalence | 2 | 2015 | 2564 | 0.080 |
Why?
| Activities of Daily Living | 2 | 2003 | 384 | 0.080 |
Why?
| Phosphoglycerate Kinase | 1 | 2009 | 2 | 0.080 |
Why?
| Antibody Formation | 2 | 2007 | 291 | 0.080 |
Why?
| Sarcosine | 1 | 2009 | 9 | 0.080 |
Why?
| CpG Islands | 2 | 2023 | 152 | 0.080 |
Why?
| Decision Trees | 2 | 2020 | 90 | 0.080 |
Why?
| Delivery of Health Care | 1 | 2016 | 900 | 0.080 |
Why?
| Retinitis Pigmentosa | 1 | 2008 | 20 | 0.080 |
Why?
| AIDS-Related Opportunistic Infections | 1 | 2010 | 123 | 0.080 |
Why?
| Pregnancy | 4 | 2017 | 6423 | 0.080 |
Why?
| Peptide Library | 2 | 2007 | 84 | 0.080 |
Why?
| Androgens | 2 | 2009 | 177 | 0.080 |
Why?
| Genes, Recessive | 1 | 2008 | 76 | 0.080 |
Why?
| Follow-Up Studies | 4 | 2019 | 4896 | 0.070 |
Why?
| Psoriasis | 1 | 2009 | 87 | 0.070 |
Why?
| Anti-HIV Agents | 1 | 2015 | 757 | 0.070 |
Why?
| Acculturation | 1 | 2008 | 51 | 0.070 |
Why?
| Homozygote | 1 | 2008 | 195 | 0.070 |
Why?
| Complex Mixtures | 1 | 2007 | 11 | 0.070 |
Why?
| Proteins | 2 | 2003 | 944 | 0.070 |
Why?
| Models, Molecular | 2 | 2019 | 1488 | 0.070 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 2007 | 46 | 0.070 |
Why?
| Blindness | 1 | 2008 | 38 | 0.070 |
Why?
| Uncertainty | 1 | 2008 | 122 | 0.070 |
Why?
| Glaucoma | 1 | 2010 | 221 | 0.070 |
Why?
| Confidence Intervals | 1 | 2008 | 318 | 0.070 |
Why?
| Practice Patterns, Physicians' | 1 | 2016 | 1274 | 0.070 |
Why?
| Mice, Nude | 2 | 2021 | 680 | 0.070 |
Why?
| Respiratory Tract Infections | 1 | 2011 | 376 | 0.070 |
Why?
| Pituitary Neoplasms | 1 | 2009 | 180 | 0.070 |
Why?
| Leisure Activities | 1 | 2007 | 29 | 0.070 |
Why?
| Lymphatic Metastasis | 2 | 2019 | 320 | 0.070 |
Why?
| Antibodies, Neoplasm | 1 | 2007 | 34 | 0.070 |
Why?
| Exercise | 1 | 2018 | 1934 | 0.070 |
Why?
| Genes, myc | 1 | 2007 | 47 | 0.070 |
Why?
| Self Concept | 1 | 2009 | 240 | 0.070 |
Why?
| Decision Theory | 1 | 2006 | 1 | 0.070 |
Why?
| Socioeconomic Factors | 2 | 2008 | 1214 | 0.070 |
Why?
| Nails | 1 | 2007 | 12 | 0.070 |
Why?
| Information Storage and Retrieval | 1 | 2007 | 108 | 0.070 |
Why?
| Genome, Human | 4 | 2016 | 393 | 0.070 |
Why?
| Mutation, Missense | 1 | 2008 | 316 | 0.070 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3630 | 0.070 |
Why?
| Genome, Bacterial | 2 | 2006 | 134 | 0.070 |
Why?
| Genes, MHC Class II | 1 | 2006 | 73 | 0.060 |
Why?
| Molecular Sequence Data | 3 | 2006 | 2833 | 0.060 |
Why?
| Pharynx | 1 | 2006 | 58 | 0.060 |
Why?
| DNA, Bacterial | 2 | 2006 | 323 | 0.060 |
Why?
| Serine Endopeptidases | 1 | 2007 | 120 | 0.060 |
Why?
| Haemophilus Infections | 1 | 2006 | 40 | 0.060 |
Why?
| Arsenic | 1 | 2007 | 63 | 0.060 |
Why?
| Cell Cycle Proteins | 2 | 2007 | 583 | 0.060 |
Why?
| Haemophilus influenzae | 1 | 2006 | 64 | 0.060 |
Why?
| Death Certificates | 1 | 2006 | 29 | 0.060 |
Why?
| Apoptosis | 3 | 2021 | 2489 | 0.060 |
Why?
| Biotinylation | 1 | 2005 | 29 | 0.060 |
Why?
| United States | 7 | 2018 | 13913 | 0.060 |
Why?
| Calibration | 2 | 2022 | 140 | 0.060 |
Why?
| GATA3 Transcription Factor | 1 | 2005 | 25 | 0.060 |
Why?
| Diabetic Retinopathy | 1 | 2008 | 179 | 0.060 |
Why?
| Molecular Mimicry | 1 | 2005 | 38 | 0.060 |
Why?
| Quantitative Trait Loci | 1 | 2008 | 352 | 0.060 |
Why?
| Antibodies, Anti-Idiotypic | 1 | 2005 | 58 | 0.060 |
Why?
| Lipids | 1 | 2009 | 628 | 0.060 |
Why?
| Hydrogen Bonding | 1 | 2005 | 149 | 0.060 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2005 | 54 | 0.060 |
Why?
| Estrogens | 1 | 2008 | 348 | 0.060 |
Why?
| Disease-Free Survival | 3 | 2017 | 647 | 0.060 |
Why?
| Sequence Homology, Amino Acid | 1 | 2005 | 371 | 0.060 |
Why?
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 54 | 0.060 |
Why?
| Histocompatibility Antigens Class II | 1 | 2006 | 363 | 0.060 |
Why?
| Environmental Pollutants | 1 | 2007 | 143 | 0.060 |
Why?
| Protein Interaction Mapping | 1 | 2005 | 107 | 0.060 |
Why?
| Area Under Curve | 2 | 2020 | 306 | 0.060 |
Why?
| CD8-Positive T-Lymphocytes | 2 | 2023 | 855 | 0.060 |
Why?
| Protein Structure, Secondary | 1 | 2005 | 342 | 0.060 |
Why?
| Retinal Rod Photoreceptor Cells | 1 | 2004 | 14 | 0.060 |
Why?
| Poisson Distribution | 1 | 2004 | 73 | 0.060 |
Why?
| Retinal Cone Photoreceptor Cells | 1 | 2004 | 16 | 0.060 |
Why?
| Environmental Monitoring | 1 | 2007 | 309 | 0.060 |
Why?
| Linkage Disequilibrium | 1 | 2005 | 257 | 0.060 |
Why?
| Bed Occupancy | 1 | 2024 | 13 | 0.060 |
Why?
| Granulomatous Disease, Chronic | 1 | 2004 | 53 | 0.060 |
Why?
| Body Mass Index | 2 | 2016 | 2274 | 0.060 |
Why?
| Sputum | 1 | 2006 | 302 | 0.060 |
Why?
| Culture Techniques | 1 | 2004 | 81 | 0.060 |
Why?
| Cancer Vaccines | 1 | 2005 | 164 | 0.060 |
Why?
| Fluorescent Antibody Technique | 2 | 2020 | 377 | 0.060 |
Why?
| Bacterial Typing Techniques | 1 | 2004 | 43 | 0.060 |
Why?
| Pedigree | 2 | 2019 | 483 | 0.050 |
Why?
| Gallium Radioisotopes | 1 | 2023 | 14 | 0.050 |
Why?
| Otitis Media | 1 | 2006 | 160 | 0.050 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2009 | 820 | 0.050 |
Why?
| Genetic Heterogeneity | 1 | 2004 | 58 | 0.050 |
Why?
| Genetics, Population | 1 | 2005 | 200 | 0.050 |
Why?
| Polybrominated Biphenyls | 1 | 2003 | 2 | 0.050 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 1 | 2004 | 74 | 0.050 |
Why?
| Cause of Death | 1 | 2006 | 395 | 0.050 |
Why?
| Personality Inventory | 1 | 2004 | 139 | 0.050 |
Why?
| Antibodies, Monoclonal | 2 | 2012 | 1368 | 0.050 |
Why?
| Expressed Sequence Tags | 1 | 2003 | 40 | 0.050 |
Why?
| Immunophenotyping | 2 | 2020 | 310 | 0.050 |
Why?
| Wnt Proteins | 2 | 2020 | 126 | 0.050 |
Why?
| Signal-To-Noise Ratio | 1 | 2023 | 68 | 0.050 |
Why?
| Immunity, Innate | 1 | 2009 | 804 | 0.050 |
Why?
| Asthma | 2 | 2007 | 2225 | 0.050 |
Why?
| GTPase-Activating Proteins | 1 | 2023 | 81 | 0.050 |
Why?
| Macrophages | 1 | 2011 | 1489 | 0.050 |
Why?
| Bile Ducts | 1 | 2003 | 68 | 0.050 |
Why?
| Biological Specimen Banks | 1 | 2024 | 96 | 0.050 |
Why?
| Antigens, Neoplasm | 1 | 2005 | 308 | 0.050 |
Why?
| Artifacts | 1 | 2023 | 127 | 0.050 |
Why?
| Hyperplasia | 1 | 2003 | 175 | 0.050 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 2023 | 135 | 0.050 |
Why?
| Hospitalization | 2 | 2024 | 2079 | 0.050 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 486 | 0.050 |
Why?
| Breast | 1 | 2003 | 140 | 0.050 |
Why?
| Biguanides | 1 | 2022 | 12 | 0.050 |
Why?
| Bone Morphogenetic Proteins | 1 | 2023 | 129 | 0.050 |
Why?
| Receptors, Antigen, B-Cell | 1 | 2023 | 126 | 0.050 |
Why?
| Complement System Proteins | 1 | 2005 | 319 | 0.050 |
Why?
| Selection Bias | 1 | 2022 | 37 | 0.050 |
Why?
| Motor Activity | 1 | 2007 | 684 | 0.050 |
Why?
| Lymphoma, B-Cell | 1 | 2003 | 103 | 0.050 |
Why?
| Membrane Proteins | 1 | 2008 | 1119 | 0.050 |
Why?
| Sarcoma, Ewing | 1 | 2003 | 87 | 0.050 |
Why?
| Calcium Signaling | 1 | 2004 | 252 | 0.050 |
Why?
| Genes, BRCA2 | 1 | 2002 | 22 | 0.050 |
Why?
| Benchmarking | 1 | 2023 | 176 | 0.050 |
Why?
| Biomedical Research | 1 | 2008 | 640 | 0.050 |
Why?
| Yeasts | 1 | 2002 | 52 | 0.050 |
Why?
| Retrospective Studies | 4 | 2024 | 14553 | 0.050 |
Why?
| Genes, BRCA1 | 1 | 2002 | 30 | 0.050 |
Why?
| Evaluation Studies as Topic | 1 | 2002 | 176 | 0.050 |
Why?
| Vaccines, Synthetic | 1 | 2022 | 126 | 0.050 |
Why?
| Seasons | 1 | 2024 | 493 | 0.050 |
Why?
| Amino Acid Sequence | 1 | 2005 | 2057 | 0.050 |
Why?
| Epithelial Cells | 2 | 2008 | 1063 | 0.050 |
Why?
| Entropy | 1 | 2021 | 38 | 0.050 |
Why?
| T-Lymphocyte Subsets | 1 | 2023 | 412 | 0.040 |
Why?
| Dose-Response Relationship, Drug | 1 | 2005 | 2016 | 0.040 |
Why?
| Evolution, Molecular | 1 | 2005 | 462 | 0.040 |
Why?
| Health Care Surveys | 2 | 2016 | 558 | 0.040 |
Why?
| Genetic Testing | 1 | 2004 | 422 | 0.040 |
Why?
| Citrullination | 1 | 2020 | 12 | 0.040 |
Why?
| Drosophila Proteins | 1 | 2002 | 187 | 0.040 |
Why?
| Milk, Human | 1 | 2022 | 151 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 954 | 0.040 |
Why?
| Somatostatin-Secreting Cells | 1 | 2020 | 3 | 0.040 |
Why?
| Interleukin-2 | 1 | 2022 | 437 | 0.040 |
Why?
| Phosphorylation | 2 | 2018 | 1716 | 0.040 |
Why?
| Receptors, Retinoic Acid | 1 | 2020 | 41 | 0.040 |
Why?
| Somatostatin | 1 | 2020 | 56 | 0.040 |
Why?
| Citalopram | 1 | 2020 | 30 | 0.040 |
Why?
| Human Embryonic Stem Cells | 1 | 2020 | 23 | 0.040 |
Why?
| Leukocytes, Mononuclear | 1 | 2023 | 546 | 0.040 |
Why?
| Immunity, Cellular | 1 | 2022 | 265 | 0.040 |
Why?
| RNA, Ribosomal, 16S | 1 | 2022 | 524 | 0.040 |
Why?
| Policy | 1 | 2021 | 143 | 0.040 |
Why?
| Support Vector Machine | 1 | 2020 | 38 | 0.040 |
Why?
| Polycomb Repressive Complex 2 | 3 | 2007 | 63 | 0.040 |
Why?
| Nutrition Surveys | 1 | 2021 | 260 | 0.040 |
Why?
| Embryo, Mammalian | 1 | 2020 | 224 | 0.040 |
Why?
| Quality of Life | 2 | 2009 | 2695 | 0.040 |
Why?
| Immunoblotting | 3 | 2005 | 306 | 0.040 |
Why?
| International Classification of Diseases | 1 | 2020 | 122 | 0.040 |
Why?
| Allosteric Regulation | 1 | 2019 | 94 | 0.040 |
Why?
| Nanog Homeobox Protein | 1 | 2019 | 13 | 0.040 |
Why?
| Electroencephalography | 1 | 2021 | 409 | 0.040 |
Why?
| Cognition Disorders | 1 | 2003 | 505 | 0.040 |
Why?
| Polymethyl Methacrylate | 1 | 2019 | 22 | 0.040 |
Why?
| Binding Sites | 2 | 2017 | 1251 | 0.040 |
Why?
| Schizophrenic Psychology | 1 | 2019 | 94 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2020 | 334 | 0.040 |
Why?
| Receptors, Antigen, T-Cell | 1 | 2023 | 707 | 0.040 |
Why?
| SEER Program | 1 | 2019 | 202 | 0.040 |
Why?
| Breast Feeding | 1 | 2022 | 424 | 0.040 |
Why?
| Interferon-gamma | 1 | 2022 | 773 | 0.040 |
Why?
| Herpesvirus 3, Human | 1 | 2022 | 331 | 0.040 |
Why?
| Virulence | 2 | 2011 | 255 | 0.040 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 235 | 0.040 |
Why?
| Seizures | 1 | 2021 | 402 | 0.040 |
Why?
| B-Lymphocytes | 1 | 2023 | 816 | 0.040 |
Why?
| Epigenesis, Genetic | 2 | 2017 | 615 | 0.040 |
Why?
| Mice, SCID | 1 | 2019 | 350 | 0.040 |
Why?
| Prostatic Hyperplasia | 2 | 2008 | 41 | 0.040 |
Why?
| Protein Domains | 1 | 2019 | 254 | 0.040 |
Why?
| Adjuvants, Immunologic | 1 | 2019 | 222 | 0.040 |
Why?
| Autoantigens | 1 | 2020 | 420 | 0.040 |
Why?
| Inflammation Mediators | 1 | 2020 | 505 | 0.030 |
Why?
| Mice, Knockout | 2 | 2020 | 2888 | 0.030 |
Why?
| Protein Stability | 1 | 2018 | 162 | 0.030 |
Why?
| National Cancer Institute (U.S.) | 1 | 2017 | 43 | 0.030 |
Why?
| Databases, Protein | 2 | 2007 | 61 | 0.030 |
Why?
| Taiwan | 2 | 2007 | 19 | 0.030 |
Why?
| Mice, Inbred NOD | 1 | 2019 | 587 | 0.030 |
Why?
| Fibroblasts | 1 | 2002 | 954 | 0.030 |
Why?
| Michigan | 2 | 2007 | 104 | 0.030 |
Why?
| Tissue Scaffolds | 1 | 2019 | 203 | 0.030 |
Why?
| After-Hours Care | 1 | 2016 | 14 | 0.030 |
Why?
| Analgesia, Patient-Controlled | 1 | 2016 | 11 | 0.030 |
Why?
| Sterilization, Tubal | 1 | 2016 | 13 | 0.030 |
Why?
| Radiotherapy, Intensity-Modulated | 1 | 2017 | 129 | 0.030 |
Why?
| Platelet Count | 1 | 2016 | 82 | 0.030 |
Why?
| Live Birth | 1 | 2016 | 57 | 0.030 |
Why?
| Survivors | 1 | 2019 | 464 | 0.030 |
Why?
| Enhancer of Zeste Homolog 2 Protein | 2 | 2007 | 41 | 0.030 |
Why?
| Prostate-Specific Antigen | 2 | 2008 | 160 | 0.030 |
Why?
| Enzyme Inhibitors | 1 | 2019 | 827 | 0.030 |
Why?
| Prostate | 2 | 2008 | 173 | 0.030 |
Why?
| Chemotherapy, Adjuvant | 1 | 2017 | 377 | 0.030 |
Why?
| Personnel Staffing and Scheduling | 1 | 2016 | 89 | 0.030 |
Why?
| Cognition | 1 | 2003 | 1125 | 0.030 |
Why?
| HEK293 Cells | 1 | 2018 | 697 | 0.030 |
Why?
| Family | 1 | 2019 | 646 | 0.030 |
Why?
| Cholesterol, HDL | 1 | 2016 | 205 | 0.030 |
Why?
| Antibodies, Viral | 1 | 2019 | 602 | 0.030 |
Why?
| Gene Regulatory Networks | 2 | 2007 | 280 | 0.030 |
Why?
| Genes, Bacterial | 2 | 2006 | 159 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 2011 | 1033 | 0.030 |
Why?
| Particulate Matter | 1 | 2017 | 247 | 0.030 |
Why?
| Rats | 1 | 2003 | 5487 | 0.030 |
Why?
| Cell Movement | 1 | 2019 | 950 | 0.030 |
Why?
| Epistasis, Genetic | 1 | 2015 | 70 | 0.030 |
Why?
| Cesarean Section | 1 | 2016 | 183 | 0.030 |
Why?
| Neuropsychological Tests | 1 | 2019 | 1016 | 0.030 |
Why?
| Occupational Exposure | 1 | 2018 | 302 | 0.030 |
Why?
| Cardiovascular System | 1 | 2016 | 136 | 0.030 |
Why?
| Skin Neoplasms | 1 | 2002 | 830 | 0.030 |
Why?
| Genes, Essential | 1 | 2014 | 22 | 0.030 |
Why?
| GATA1 Transcription Factor | 1 | 2014 | 18 | 0.030 |
Why?
| Molecular Sequence Annotation | 1 | 2014 | 88 | 0.030 |
Why?
| Data Collection | 2 | 2007 | 653 | 0.030 |
Why?
| Receptors, Estrogen | 2 | 2007 | 422 | 0.030 |
Why?
| Methylation | 1 | 2014 | 228 | 0.030 |
Why?
| North America | 1 | 2014 | 294 | 0.030 |
Why?
| Organ Specificity | 1 | 2014 | 295 | 0.030 |
Why?
| Pilot Projects | 1 | 2018 | 1597 | 0.030 |
Why?
| Host-Parasite Interactions | 1 | 2014 | 103 | 0.030 |
Why?
| Gene-Environment Interaction | 1 | 2014 | 185 | 0.030 |
Why?
| Species Specificity | 1 | 2014 | 568 | 0.030 |
Why?
| Schizosaccharomyces | 1 | 2013 | 59 | 0.030 |
Why?
| Cell Line | 2 | 2009 | 2780 | 0.030 |
Why?
| Emergency Service, Hospital | 1 | 2024 | 1920 | 0.030 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2013 | 88 | 0.030 |
Why?
| Pandemics | 1 | 2021 | 1500 | 0.030 |
Why?
| Sequence Analysis, DNA | 2 | 2006 | 778 | 0.020 |
Why?
| Cytokines | 1 | 2020 | 2022 | 0.020 |
Why?
| Carboplatin | 1 | 2012 | 139 | 0.020 |
Why?
| Databases, Nucleic Acid | 1 | 2012 | 33 | 0.020 |
Why?
| Cetuximab | 1 | 2012 | 94 | 0.020 |
Why?
| Prospective Studies | 3 | 2009 | 7158 | 0.020 |
Why?
| Paclitaxel | 1 | 2012 | 218 | 0.020 |
Why?
| In Situ Hybridization | 1 | 2011 | 296 | 0.020 |
Why?
| Quinazolines | 1 | 2012 | 243 | 0.020 |
Why?
| Mass Screening | 1 | 2018 | 1192 | 0.020 |
Why?
| Depression | 1 | 2019 | 1323 | 0.020 |
Why?
| Insulin | 1 | 2020 | 2330 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2020 | 5468 | 0.020 |
Why?
| Electrophoresis | 1 | 2009 | 31 | 0.020 |
Why?
| Pituitary Hormones | 1 | 2009 | 16 | 0.020 |
Why?
| Cell Death | 1 | 2011 | 353 | 0.020 |
Why?
| Sarcosine Dehydrogenase | 1 | 2009 | 1 | 0.020 |
Why?
| Glycine N-Methyltransferase | 1 | 2009 | 4 | 0.020 |
Why?
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2009 | 10 | 0.020 |
Why?
| Ophthalmoscopy | 1 | 2008 | 35 | 0.020 |
Why?
| Interleukin-1beta | 1 | 2011 | 369 | 0.020 |
Why?
| Electroretinography | 1 | 2008 | 45 | 0.020 |
Why?
| Blood Pressure | 1 | 2016 | 1736 | 0.020 |
Why?
| Consanguinity | 1 | 2008 | 47 | 0.020 |
Why?
| Antineoplastic Agents | 2 | 2012 | 2045 | 0.020 |
Why?
| Gene Library | 1 | 2009 | 115 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2009 | 298 | 0.020 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1560 | 0.020 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2011 | 324 | 0.020 |
Why?
| Golgi Apparatus | 1 | 2008 | 100 | 0.020 |
Why?
| Chemical Fractionation | 1 | 2007 | 29 | 0.020 |
Why?
| Genes | 1 | 2008 | 225 | 0.020 |
Why?
| Gene Knockdown Techniques | 1 | 2009 | 317 | 0.020 |
Why?
| Keratinocytes | 1 | 2009 | 244 | 0.020 |
Why?
| Chromosomes, Human, 16-18 | 1 | 2007 | 3 | 0.020 |
Why?
| Chromosomes, Human, 6-12 and X | 1 | 2007 | 3 | 0.020 |
Why?
| Polycomb-Group Proteins | 1 | 2007 | 28 | 0.020 |
Why?
| DNA Primers | 1 | 2008 | 508 | 0.020 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2007 | 28 | 0.020 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2007 | 48 | 0.020 |
Why?
| Feedback | 1 | 2008 | 163 | 0.020 |
Why?
| Bacteriophage T7 | 1 | 2007 | 5 | 0.020 |
Why?
| Seaweed | 1 | 2007 | 2 | 0.020 |
Why?
| Agaricales | 1 | 2007 | 3 | 0.020 |
Why?
| Chromatography, Liquid | 1 | 2009 | 426 | 0.020 |
Why?
| Tomography, Optical Coherence | 1 | 2008 | 186 | 0.020 |
Why?
| Neoplasm Transplantation | 1 | 2007 | 253 | 0.020 |
Why?
| Models, Animal | 1 | 2009 | 376 | 0.020 |
Why?
| Oxidative Stress | 1 | 2013 | 1264 | 0.020 |
Why?
| Subtraction Technique | 1 | 2007 | 23 | 0.020 |
Why?
| Data Display | 1 | 2007 | 20 | 0.020 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 756 | 0.020 |
Why?
| Autophagy-Related Proteins | 1 | 2007 | 42 | 0.020 |
Why?
| Chromosomes, Human | 1 | 2007 | 41 | 0.020 |
Why?
| Seafood | 1 | 2007 | 27 | 0.020 |
Why?
| Food Contamination | 1 | 2007 | 44 | 0.020 |
Why?
| Lymphoma | 1 | 2008 | 198 | 0.020 |
Why?
| Oryza | 1 | 2007 | 31 | 0.020 |
Why?
| Sequence Analysis, Protein | 1 | 2006 | 28 | 0.020 |
Why?
| Television | 1 | 2007 | 74 | 0.020 |
Why?
| Surveys and Questionnaires | 1 | 2019 | 5437 | 0.020 |
Why?
| Inhibitory Concentration 50 | 1 | 2006 | 86 | 0.020 |
Why?
| Amino Acid Motifs | 1 | 2007 | 215 | 0.020 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2013 | 1058 | 0.020 |
Why?
| Fishes | 1 | 2007 | 94 | 0.020 |
Why?
| Water Supply | 1 | 2007 | 74 | 0.020 |
Why?
| Managed Care Programs | 1 | 2007 | 132 | 0.020 |
Why?
| Nucleic Acid Hybridization | 1 | 2006 | 188 | 0.020 |
Why?
| Urban Health | 1 | 2006 | 79 | 0.020 |
Why?
| Ear, Middle | 1 | 2006 | 91 | 0.020 |
Why?
| Drug Design | 1 | 2007 | 158 | 0.020 |
Why?
| Lipid Metabolism | 1 | 2009 | 503 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2011 | 1205 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2009 | 1311 | 0.020 |
Why?
| Fibrocystic Breast Disease | 1 | 2005 | 2 | 0.020 |
Why?
| Databases as Topic | 1 | 2005 | 59 | 0.010 |
Why?
| E2F Transcription Factors | 1 | 2005 | 59 | 0.010 |
Why?
| Base Composition | 1 | 2005 | 76 | 0.010 |
Why?
| Oligonucleotide Probes | 1 | 2005 | 49 | 0.010 |
Why?
| DNA Probes | 1 | 2005 | 60 | 0.010 |
Why?
| Housing | 1 | 2006 | 130 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 362 | 0.010 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2004 | 38 | 0.010 |
Why?
| Bone Morphogenetic Protein Receptors | 1 | 2004 | 6 | 0.010 |
Why?
| Autopsy | 1 | 2004 | 92 | 0.010 |
Why?
| Smad Proteins | 1 | 2004 | 40 | 0.010 |
Why?
| Receptors, Growth Factor | 1 | 2004 | 55 | 0.010 |
Why?
| Skin | 1 | 2009 | 725 | 0.010 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2004 | 41 | 0.010 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 399 | 0.010 |
Why?
| Random Allocation | 1 | 2005 | 347 | 0.010 |
Why?
| Recombination, Genetic | 1 | 2005 | 189 | 0.010 |
Why?
| Oligonucleotides | 1 | 2004 | 146 | 0.010 |
Why?
| Receptors, Progesterone | 1 | 2005 | 341 | 0.010 |
Why?
| Retinal Diseases | 1 | 2004 | 87 | 0.010 |
Why?
| Selection, Genetic | 1 | 2005 | 252 | 0.010 |
Why?
| Overweight | 1 | 2007 | 531 | 0.010 |
Why?
| Spermine | 1 | 2002 | 28 | 0.010 |
Why?
| Spermidine | 1 | 2002 | 18 | 0.010 |
Why?
| Internet | 1 | 2007 | 620 | 0.010 |
Why?
| Genes, Tumor Suppressor | 1 | 2002 | 84 | 0.010 |
Why?
| Adenosine Monophosphate | 1 | 2002 | 63 | 0.010 |
Why?
| California | 1 | 2003 | 400 | 0.010 |
Why?
| Cell Cycle | 1 | 2004 | 583 | 0.010 |
Why?
| Mental Recall | 1 | 2003 | 191 | 0.010 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 836 | 0.010 |
Why?
| Biopsy, Needle | 1 | 2002 | 187 | 0.010 |
Why?
| Mutation | 1 | 2012 | 3706 | 0.010 |
Why?
| Psychiatric Status Rating Scales | 1 | 2003 | 534 | 0.010 |
Why?
| Comorbidity | 1 | 2006 | 1551 | 0.010 |
Why?
| Proto-Oncogene Proteins | 1 | 2004 | 634 | 0.010 |
Why?
| Bacterial Proteins | 1 | 2006 | 838 | 0.010 |
Why?
| Transfection | 1 | 2002 | 918 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2009 | 4077 | 0.010 |
Why?
| RNA | 1 | 2005 | 877 | 0.010 |
Why?
| Predictive Value of Tests | 1 | 2002 | 1951 | 0.010 |
Why?
| Stroke | 1 | 2003 | 1072 | 0.010 |
Why?
| Aging | 1 | 2003 | 1774 | 0.010 |
Why?
|
|
Ghosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|